Ami Fadia
Stock Analyst at Needham
(4.97)
# 87
Out of 4,690 analysts
634
Total ratings
59.6%
Success rate
35.1%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterated: Buy | $240 | $207.88 | +15.45% | 35 | Aug 27, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $292 → $310 | $244.54 | +26.77% | 72 | Aug 26, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $5 | $1.39 | +259.71% | 21 | Aug 14, 2026 | |
| ACAD ACADIA Pharmaceuticals | Rated: Buy | $38 → $41 | $29.11 | +40.85% | 39 | Aug 12, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $50 → $66 | $40.98 | +61.05% | 11 | Aug 12, 2026 | |
| COGT Cogent Biosciences | Rated: Hold | n/a | $34.67 | - | 28 | Aug 11, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $255 → $268 | $199.02 | +34.66% | 26 | Aug 10, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $575 → $582 | $344.75 | +68.82% | 26 | Aug 6, 2026 | |
| GHRS GH Research | Maintained: Buy | $32 → $39 | $27.94 | +39.58% | 6 | Aug 6, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $11 → $18 | $4.99 | +260.72% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $39.21 | +27.52% | 53 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $204 | $154.06 | +32.42% | 44 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $14 | $4.20 | +233.33% | 44 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $47.41 | +30.77% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $256 | $218.50 | +17.16% | 70 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $12.60 | +257.14% | 8 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.29 | - | 10 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | €82.80 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $10.83 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $8.48 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $3.81 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.34 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $14.48 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $17.54 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $13.97 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $25.76 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $0.000001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $24 | $0.3266 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $1.5 | $0.000001 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $9 | $16.79 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $14 | $36.44 | n/a | 11 | Aug 6, 2020 |
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $240
Current: $207.88
Upside: +15.45%
Jazz Pharmaceuticals
Aug 26, 2026
Rated: Buy
Price Target: $292 → $310
Current: $244.54
Upside: +26.77%
Neumora Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
ACADIA Pharmaceuticals
Aug 12, 2026
Rated: Buy
Price Target: $38 → $41
Current: $29.11
Upside: +40.85%
Definium Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $50 → $66
Current: $40.98
Upside: +61.05%
Cogent Biosciences
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $34.67
Upside: -
Axsome Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $255 → $268
Current: $199.02
Upside: +34.66%
Praxis Precision Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $575 → $582
Current: $344.75
Upside: +68.82%
GH Research
Aug 6, 2026
Maintained: Buy
Price Target: $32 → $39
Current: $27.94
Upside: +39.58%
Immuneering
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $18
Current: $4.99
Upside: +260.72%
Aug 4, 2026
Maintained: Buy
Price Target: $45 → $50
Current: $39.21
Upside: +27.52%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $204
Current: $154.06
Upside: +32.42%
Jul 30, 2026
Maintained: Buy
Price Target: $15 → $14
Current: $4.20
Upside: +233.33%
Jul 29, 2026
Reiterated: Buy
Price Target: $62
Current: $47.41
Upside: +30.77%
Jul 29, 2026
Maintained: Buy
Price Target: $256
Current: $218.50
Upside: +17.16%
Jul 27, 2026
Maintained: Buy
Price Target: $45
Current: $12.60
Upside: +257.14%
Jul 16, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.29
Upside: -
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: €82.80
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $10.83
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $8.48
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $3.81
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $16.34
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $14.48
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $17.54
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $13.97
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $25.76
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Dec 30, 2020
Maintained: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Dec 2, 2020
Maintained: Buy
Price Target: $19 → $24
Current: $0.3266
Upside: n/a
Oct 1, 2020
Maintained: Hold
Price Target: $1 → $1.5
Current: $0.000001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $8 → $9
Current: $16.79
Upside: n/a
Aug 6, 2020
Maintained: Hold
Price Target: $12 → $14
Current: $36.44
Upside: n/a